Asset
R-343
Rigel Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01591044 | phase2 | completed | 2012-07-01 | 2013-07-01 | Rigel Pharmaceuticals | A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma |
FDA applications (0)
This company has no applications containing this asset.